- Home
- CERO vs OP Comparison
CERO vs OP Comparison
Compare CERO & OP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- OP
- Stock Information
- Founded
- CERO 2017
- OP 2021
- Country
- CERO United States
- OP Greece
- Employees
- CERO N/A
- OP N/A
- Industry
- CERO
- OP
- Sector
- CERO
- OP
- Exchange
- CERO Nasdaq
- OP Nasdaq
- Market Cap
- CERO 8.4M
- OP 8.3M
- IPO Year
- CERO N/A
- OP N/A
- Fundamental
- Price
- CERO $1.36
- OP $0.99
- Analyst Decision
- CERO
- OP
- Analyst Count
- CERO 0
- OP 0
- Target Price
- CERO N/A
- OP N/A
- AVG Volume (30 Days)
- CERO 188.7K
- OP 11.8K
- Earning Date
- CERO 03-18-2025
- OP 04-10-2025
- Dividend Yield
- CERO N/A
- OP N/A
- EPS Growth
- CERO N/A
- OP N/A
- EPS
- CERO N/A
- OP N/A
- Revenue
- CERO N/A
- OP $25,729,000.00
- Revenue This Year
- CERO N/A
- OP N/A
- Revenue Next Year
- CERO N/A
- OP N/A
- P/E Ratio
- CERO N/A
- OP N/A
- Revenue Growth
- CERO N/A
- OP 36.33
- 52 Week Low
- CERO $1.26
- OP $0.88
- 52 Week High
- CERO $376.00
- OP $3.15
- Technical
- Relative Strength Index (RSI)
- CERO 32.62
- OP 38.48
- Support Level
- CERO $1.33
- OP $0.88
- Resistance Level
- CERO $1.54
- OP $1.02
- Average True Range (ATR)
- CERO 0.18
- OP 0.06
- MACD
- CERO 0.09
- OP -0.01
- Stochastic Oscillator
- CERO 11.80
- OP 42.31
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.
About OP OceanPal Inc.
OceanPal Inc is a provider of shipping transportation services. It specializes in the ownership of vessels. Each of its vessels is owned through a separate wholly-owned subsidiary.